NCT07173192

Brief Summary

Psychoeducation provided to family members caring for individuals with schizophrenia. Has been found to positively impact caregivers' psychological well-being and the effective management of schizophrenia patients.However, further experimental studies are recommended in this area, along with support for caregivers' psychological well-being. Primary caregivers, which includes both psychoeducation and applications aimed at developing coping skills, on the care burden, psychological well-being,and self-efficacy. Considering the gaps in the literature, the aim of this study is to evaluate the effect of an individual empowerment program applied to primary caregivers of patients diagnosed with schizophrenia on the burden of care, psychological well-being, and self-efficacy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2026

Completed
Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

7 months

First QC Date

September 7, 2025

Last Update Submit

September 7, 2025

Conditions

Keywords

Self EfficacyBurden, CaregiverPsychological Well Beingschizophrenia

Outcome Measures

Primary Outcomes (3)

  • The psychological well-being scale based on the individual empowerment program will be used to measure the care burden of individuals providing primary care to those diagnosed with schizophrenia. (time frame: 6 week)

    The training will be conducted in person.

    6 week

  • The care burden scale based on the individual empowerment program will be used to measure the care burden for individuals providing primary care to individuals diagnosed with schizophrenia. (Time frame: 6 weeks)

    Face-to-face training will be provided.

    6 week

  • The self-efficacy scale based on the individual empowerment program will be used to measure the care burden of individuals providing primary care to people diagnosed with schizophrenia. (time frame: 6 weeks)

    The training will be conducted in person.

    6 week

Study Arms (2)

experimental group

EXPERIMENTAL

Data collection tools will be administered as a pre-test to individuals in the experimental and control groups. Individuals in the experimental group will receive individual empowerment training sessions as part of a six-session individual empowerment program.

Behavioral: Individual empowerment program

control group

NO INTERVENTION

No intervention will be performed on individuals in the control group; these individuals will receive standard discharge education.

Interventions

Data collection tools will be applied to individuals in the experimental and control groups as a pre-test. Individual empowerment training sessions will be applied to individuals in the experimental group totaling (6 sessions) as part of the individual empowerment program. No intervention will be performed on individuals in the control group; they will receive standard discharge education. Data collection tools will be applied to individuals in both groups for post-tests immediately after the experimental group completes all individual empowerment program sessions.

experimental group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being the primary caregiver of a patient diagnosed with schizophrenia and other psychotic disorders Volunteering to participate in the study Being 18 years of age or older Being literate Not having a psychiatric illness (diagnosis) Not having a serious mental or physical disorder that prevents communication

You may not qualify if:

  • Providing care to patients with severe organic brain syndrome such as alcohol or substance dependence, intellectual disability, dementia, or delirium, or with a previous or current general medical condition that could impair cognitive function Withdrawal from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Arel University

Istanbul, Cevizlibağ, 34010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

SchizophreniaCaregiver BurdenPsychological Well-Being

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersStress, PsychologicalBehavioral SymptomsBehaviorPersonal Satisfaction

Study Officials

  • zeynep dağ psychiatric nurse

    Istanbul Arel University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Data will be collected face-to-face from primary caregivers of patients diagnosed with schizophrenia who are receiving treatment at Istanbul Bakırköy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital using data collection forms. Individuals who agree to participate in the study and meet the inclusion criteria will be randomized into experimental and control groups. Which caregivers included in the study will be in the intervention group and which will be in the control group will be determined according to the randomization table generated online at https://www.randomizer.org/. Group 1 will be designated as the Intervention Group, and Group 2 will be designated as the Control Group. Data collection tools will be administered to individuals in the experimental and control groups as a pre-test. Individuals in the experimental group will undergo an individual empowerment program consisting of a total of 6 individual empowerment training sessions
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Servis Hemşiresi

Study Record Dates

First Submitted

September 7, 2025

First Posted

September 15, 2025

Study Start

May 15, 2025

Primary Completion

November 30, 2025

Study Completion

February 15, 2026

Last Updated

September 15, 2025

Record last verified: 2025-09

Locations